IQVIA Institute Webinar: The Use of Medicines in the U.S.

  • July 15, 2021 - 10:00am - 11:00am

IQVIA Institute's webinar: The Use of Medicines in the U.S.: Spending and Usage Trends and Outlook to 2025 featured a meaningful discussion among a multi-stakeholder panel about the use of medicine in the U.S.

IQVIA Logo

Webinar | Thursday, July 15, 2021 | 

Click here for on-demand access to the webinar.

Background and Scope

The U.S. health system demonstrated resilience and flexibility during 2020, recovering toward its pre-pandemic levels of activity and progressing into 2021, even as the backlog of missed or delayed activity remains substantial. Medicine supply was largely maintained and spending on medicines increased by less than 1% on a net price basis.

This webinar followed the release of a new IQVIA Institute report on The Use of Medicines in the U.S.: Spending and Usage Trends and Outlook to 2025 and intended to generate meaningful discussion among a multi-stakeholder panel around timely topics related to the use of medicine in the U.S.

The report was produced independently by the IQVIA Institute as a public service, without industry or government funding, and is available for free download. The webinar is a non-commercial event by the IQVIA Institute and is open to all who register to attend (on-demand).

Agenda

  • Welcome and introductions: Murray Aitken, Executive Director, IQVIA Institute
  • Key highlights from the report on The Use of Medicines in the U.S.: Spending and Usage Trends and Outlook to 2025: Michael Kleinrock, Research Director, IQVIA Institute
  • Panel discussion
    • Restoring and strengthening the U.S. health system post-pandemic and impact on medicine use and patient care
    • Interpreting medicine spending trends and dynamics of pricing and volume
    • Understanding patient out-of-pocket costs, affordability and impact on use of medicines
  • Audience Q&A
  • Closing

Panelists:

  • Krutika Amin, PhD
    Associate Director, Program on the Affordable Care Act, Kaiser Family Foundation (KFF) 
     
  • Rena Conti, PhD
    Associate Director, Boston University
     
  • Ronna Hauser, PharmD
    Vice President of Pharmacy Affairs, NCPA
     
  • John M. O’Brien, PharmD, MPH
    President & CEO, National Pharmaceutical Council 

10:50 a.m. – Audience Q&A

11:00 a.m. – Closing


Click here for on-demand access to the webinar.